Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and efficacy of NSAIDs vs oxycodone + paracetamol for persistent non-oncological pain in the elderly
2006-001833-16Phase 4Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxycodone + paracetamol and caffeine in Chronic non-cancer pain (CNCP) (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Primary tolerability comparison. Started Nov 2009; status: terminated.
02
Drugs
oxycodone + paracetamolcaffeine
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on 2006-001833-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001833-16.